Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0311147 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jianying Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: MechanoBiology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America. Hauptthemen laut MEDLINE: Metformin, Myofibroblasts, Transforming Growth Factor beta1, Wound Healing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Technology Enterprise Consortium, Pittsburgh Foundation.
Abstract (Originalsprache)
Scar tissue formation following skin wound healing is a challenging public health problem. Skin regeneration and preventing the formation of scar tissue by currently available commercial products are largely ineffective. This study aimed to test the efficacy of a novel topical metformin lotion (ML) in inhibiting scar tissue formation during skin wound healing in rats and to determine the mechanisms of action involved. A 6% ML was prepared in our laboratory. A skin wound healing model in rats was used. The wounded rats were divided into two groups and treated daily for 10 days as follows: Group 1 received a daily application of 50 mg of control lotion, or 0% ML (totaling 100 mg of lotion per rat), and Group 2 received a daily application of 50 mg of 6% ML (totaling 100 mg of 6% ML per rat). Blood samples from the heart of each rat were analyzed for inflammatory markers, HMGB1 and IL-1β, using ELISA, and immunological and histological analyses were performed on skin tissue sections. ML decreased levels of inflammatory markers HMGB1 and IL-1β in the serum of rats and inhibited the release of HMGB1 from cell nuclei into the skin tissue matrix. Additionally, ML demonstrated anti-fibrotic properties by enhancing AMPK activity, decreasing the expression of TGF-β1, reducing the number of myofibroblasts, decreasing the production of collagen III, and increasing the expression of collagen I. ML promotes the regeneration of high-quality skin during wound healing by reducing scar tissue formation. This effect is mediated through the activation of AMPK, inhibition of TGF-β1, and a decrease in the number of myofibroblasts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MechanoBiology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA, United States of America.
- Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, United States of America.
- Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, United States of America.
ORCID-Profile: Vasyl Pastukh, Derek Maloney, James H-C Wang
Förderung
- Medical Technology Enterprise Consortium
- Pittsburgh Foundation
Zitieren
APA
Zhang, J., Shimozaki, K., Hattori, S., Pastukh, V., Maloney, D., Hogan, M. V., & Wang, J. H. (2024). Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers. PLOS ONE. https://doi.org/10.1371/journal.pone.0311147
Vancouver
Zhang J, Shimozaki K, Hattori S, Pastukh V, Maloney D, Hogan MV, et al. Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers. PLOS ONE. 2024. doi:10.1371/journal.pone.0311147
BibTeX
@article{Zhang2024,
author = {Zhang, Jianying and Shimozaki, Kengo and Hattori, Soichi and Pastukh, Vasyl and Maloney, Derek and Hogan, MaCalus V and Wang, James H-C},
title = {Metformin lotion promotes scarless skin tissue formation through AMPK activation, TGF-β1 inhibition, and reduced myofibroblast numbers},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0311147}
}
EUVIMED